http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120121234-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0007 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0012 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
| filingDate | 2011-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20120121234-A |
| titleOfInvention | Compositions useful for the prevention and treatment of diseases caused by hypoxic inducible factor 1α or vascular endothelial growth factor overexpression comprising a compound having a protoporphyrin IV structure |
| abstract | The present invention relates to compositions useful for the prevention and treatment of diseases caused by HIF-1α (Hypoxia Inducible Factor-1α) or Vascular Endothelial Growth Factor (VEGF) overactivity, protoporphyrin IX, hemin (ferriprotoporphyrin IX). ), Zinc protoporphyrin IX, cobalt protoporphyrin IX, copper protoporphyrin IX, magnesium protoporphyrin IX, tin protoporphyrin IX, tin protoporphyrin It provides a composition comprising as an active ingredient at least one selected from the group consisting of salts, solvates and hydrates thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017119417-A1 |
| priorityDate | 2011-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 374.